{"code":0,"message":"成功","totalNum":0,"result":{"docId":"101002026042270000328","docLibId":3,"headLine":"新技术有望助力1型糖尿病干细胞治疗","productCategoryId":"c0030002,c0030015,c0030016,c0030017,c0030173,c0030322","productCategoryName":"通稿新闻线路,海外中文专线,BL广播,中文亚太线,新媒体专线,新华社客户端","authors":"朱昊晨,徐谦","authorsEn":"Zhu Haochen,Xu Qian","authorsId":"zhuhaochen,unreguser","geographyCategoryId":"","columnCategoryId":"<100001><c0030002><c0030002011>,<100004><c0030173><c0030173028>,c0030322322,<100004><c0030322><c23046><c0030322206>,<100001><c0030015>,<100001><c0030016>,<100001><c0030017>","organizationId":"c0241000","newsCategoryId":"c0270121","content":"　　新华社赫尔辛基4月26日电（记者朱昊晨　徐谦）斯德哥尔摩消息：瑞典卡罗琳医学院日前发布公报说，该校研究人员参与的团队开发出一种新技术，可利用人类干细胞更稳定地制备胰岛素分泌细胞，有望推进1型糖尿病的干细胞治疗。","keywords":"糖尿病,瑞典,医学","wordCount":590,"languageId":"zh-CN","symbol":"XxjidoC000032_20260426_CBTFN0.xml","broadcastDate":"2026-04-26 16:18:04","broadcastDateTimestamp":1777191484000,"mediaTypeId":"Text","happenPlace":"","reportPlace":"","tagKeywords":"胰岛素,糖尿病,医学界,斯德哥尔摩,针对性,瑞典卡罗琳医学院,细胞培养,研究团队,干细胞报告,新技术,不够灵敏,血糖变化,细胞自主,新可能,细胞团","photoPlateNum":"","pixelHeight":null,"pixelWidth":null,"duration":null,"guidePrice":0,"previewUrl":null,"playUrl":null,"newsCategoryIdTop":"c0270121","isBought":false,"showPercentVideo":0.5,"isOrdered":false,"isCollected":false,"isViewed":false,"isDownloaded":false,"isLiked":false,"downloadCount":null,"collectedCount":null,"viewedCount":null,"tagJson":"","notionalArea":"","internalName":"国际新闻","issuerDeptId":"","issuerDept":"国际部-发稿中心","sharelink":null,"docSource":null,"attach":[],"album":null,"ordered":false,"id":"111002026042600005006","bought":false,"collected":false,"viewed":false,"downloaded":false,"liked":false}}